VOLUME
67 2006 NUMBER 3
Editorial
341 Circle of Honor. Alan J. Gelenberg and Marlene P. Freeman
[PDF]
Original Articles
342 Neural Correlates of the Affect Regulation Model in Schizophrenia
Patients With Substance Use History: A Functional Magnetic Resonance Imaging
Study. Adham Mancini-Marïe, Stéphane Potvin, Cherine Fahim, Mario
Beauregard, Boualem Mensour, and Emmanuel Stip
[Abstract]
[PDF]
351 Association Between Attention-Deficit/Hyperactivity Disorder and
Bulimia Nervosa: Analysis of 4 Case-Control Studies. Craig B. H. Surman,
Edin T. Randall, and Joseph Biederman
[Abstract]
[PDF]
355 Quetiapine in the Treatment of Anxiety in Patients With Bipolar I or
II Depression: A Secondary Analysis From a Randomized, Double-Blind,
Placebo-Controlled Study. Robert M. A. Hirschfeld, Richard H. Weisler,
Shane R. Raines, and Wayne Macfadden, for the BOLDER Study Group
[Abstract]
[PDF]
363 The Epidemiology of DSM-IV Panic Disorder and Agoraphobia in the
United States: Results From the National Epidemiologic Survey on Alcohol and
Related Conditions. Bridget F. Grant, Deborah S. Hasin, Frederick S.
Stinson, Deborah A. Dawson, Rise B. Goldstein, Sharon Smith, Boji Huang, and
Tulshi D. Saha
[Abstract]
[PDF]
375 A Pilot Study on Differences in Aggression in New York City and
Madrid, Spain, and Their Possible Impact on Suicidal Behavior. Enrique
Baca-García, Maria A. Oquendo, Jeronimo Saiz-Ruiz, J. John Mann, and Jose de
Leon
[Abstract]
[PDF]
381 An Open-Label Trial of Risperidone Augmentation for Refractory
Anxiety Disorders. Naomi M. Simon, Elizabeth A. Hoge, Diana Fischmann,
John J. Worthington III, Kelly M. Christian, Gustavo Kinrys, and Mark H.
Pollack
[Abstract]
[PDF]
386 Use of Treatment Services and Pharmacotherapy for Bipolar Disorder in
a General Population-Based Mental Health Survey. Ayal Schaffer, John
Cairney, Amy H. Cheung, Scott Veldhuizen, and Anthony J. Levitt
[Abstract]
[PDF]
394 Persistent Posttraumatic Stress Disorder Following September 11 in
Patients With Bipolar Disorder. Mark H. Pollack, Naomi M. Simon, Andrea
Fagiolini, Roger Pitman, Richard J. McNally, Andrew A. Nierenberg, Sachicko
Miyahara, Gary S. Sachs, Carol Perlman, S. Nassir Ghaemi, Michael E. Thase,
and Michael W. Otto
[Abstract]
[PDF]
400 The Effect of Dermatologic Precautions on the Incidence of Rash With
Addition of Lamotrigine in the Treatment of Bipolar I Disorder: A Randomized
Trial. Terence A. Ketter, John H. Greist, James A. Graham, Jeremy N.
Roberts, Thomas R. Thompson, and Kevin P. Nanry
[Abstract]
[PDF]
407 Selective Serotonin Reuptake Inhibitors in Autism: A Review of
Efficacy and Tolerability. Alexander Kolevzon, Karen A. Mathewson, and
Eric Hollander
[Abstract]
[PDF]
415 Atomoxetine and Adult Attention-Deficit/Hyperactivity Disorder: The
Effects of Comorbidity. Thomas J. Spencer, Stephen V. Faraone, David
Michelson, Lenard A. Adler, Fred W. Reimherr, Stephen J. Glatt, and Joseph
Biederman
[Abstract]
[PDF]
421 Effect of Mirtazapine Treatment on Body Composition and Metabolism.
Markus Laimer, Karin Kramer-Reinstadler, Markus Rauchenzauner, Theresia
Lechner-Schoner, Robert Strauss, Julia Engl, Eberhard A. Deisenhammer,
Hartmann Hinterhuber, Josef R. Patsch, and Christoph F. Ebenbichler
[Abstract]
[PDF]
425 Sociodemographic Characteristics and Cardiovascular Risk Factors in
Patients With Severe Mental Disorders Compared With the General Population. [CME]
Astrid B. Birkenaes, Anne J. Søgaard, John A. Engh, Halldora Jonsdottir,
P. Andreas Ringen, Anja Vaskinn, Svein Friis, Kjetil Sundet, Stein
Opjordsmoen, and Ole A. Andreassen
[Abstract]
[PDF]
434 Distinguishing Bipolar Major Depression From Unipolar Major
Depression With the Screening Assessment of Depression-Polarity (SAD-P).
David A. Solomon, Andrew C. Leon, Jack D. Maser, Christine J. Truman,
William Coryell, Jean Endicott, Jedediah J. Teres, and Martin B. Keller
[Abstract]
[PDF]
443 Psychoeducation and Compliance in the Treatment of Schizophrenia:
Results of the Munich Psychosis Information Project Study. Gabriele
Pitschel-Walz, Josef Bäuml, Wolfram Bender, Rolf R. Engel, Michael Wagner,
and Werner Kissling
[Abstract]
[PDF]
453 Medication Adherence and Long-Term Functional Outcomes in the
Treatment of Schizophrenia in Usual Care. Haya Ascher-Svanum, Douglas E.
Faries, Baojin Zhu, Frank R. Ernst, Marvin S. Swartz, and Jeff W. Swanson
[Abstract]
[PDF]
461 The Effects of Long-Term Clozapine Add-On Therapy on the
Rehospitalization Rate and the Mood Polarity Patterns in Bipolar Disorders.
Jae Seung Chang, Kyoo-Seob Ha, Kyu Young Lee, Yong Sik Kim, and Yong Min
Ahn
[Abstract]
[PDF]
468 Outcomes of Late-Life Anxiety Disorders During 32 Weeks of Citalopram
Treatment. Stephen Blank, Eric J. Lenze, Benoit H. Mulsant, Mary Amanda
Dew, Jordan F. Karp, M. Katherine Shear, Patricia R. Houck, Mark D. Miller,
Bruce G. Pollock, Barbara Tracey, and Charles F. Reynolds III
[Abstract]
[PDF]
473 A Double-Blind, Randomized, Placebo-Controlled, Prophylaxis Study of
Adjunctive Gabapentin for Bipolar Disorder. Eduard Vieta, José Manuel
Goikolea, Anabel Martínez-Arán, Mercè Comes, Katia Verger, Xavier Masramon,
Jose Sanchez-Moreno, and Francesc Colom
[Abstract]
[PDF]
Academic Highlights
478 Review of the Pharmacologic Management of Depression. [CME]
[PDF]
ASCP Corner
490 Use of Atypical Antipsychotics: Observations From Clinical Practice. Scott A. Spier
[PDF]
Letters To the Editor
492 Toxic Catatonia Secondary to Azithromycin. Maria Teresa Plana, Jordi Blanch, Soledad Romero, Montserrat Serra,
and Cristobal Gasto
[PDF]
493 3-Acetyl-7-Oxo-Dehydroepiandrosterone for Healing Treatment-Resistant
Posttraumatic Stress Disorder in Women: 5 Case Reports. Sharon Sageman and Richard P. Brown
[PDF]
496 Exacerbation of PTSD Symptoms With Use of Duloxetine. Michele L. Deneys and Eileen P. Ahearn
[PDF]
497 Methodological Issues in a Study of Long-Term Maintenance Therapy
With Quetiapine Versus Haloperidol Decanoate. Babatunde Adetunji, Biju Basil, Maju Mathews, Adedapo Williams, and
Thomas Osinowo
[PDF]
- Reply by Ira D. Glick and Stephen R. Marder
Book Review 499